相关实验视频
Updated: Jun 9, 2026

07:57
Integrated Compensatory Responses in a Human Model of Hemorrhage
Published on: November 20, 2016
在压力过重的人类心脏中,从补偿性缩到衰竭的进展:结构性恶化和补偿机制
Stefan Hein1, Eyal Arnon, Sawa Kostin
1Kerckhoff-Clinic, Department of Thoracic and Cardiovascular Surgery, Bad Nauheim, Germany. s.hein@kerckhoff.mpg.de
Circulation
|February 26, 2003
概括
心力衰竭的进展涉及结构性变化,如纤维化和细胞死亡,而不仅仅是缩. 肌细胞退化和细胞损失,特别是通过自和瘤,显著驱动左心室缩功能障碍.
科学领域:
- 心血管生物学 心血管生物学
- 病理学 病理学 病理学
- 细胞生物学 细胞生物学
背景情况:
- 从补偿性心脏缩到心力衰竭 (HF) 的过渡仍然不完全理解.
- 调查患有膜大动脉狭窄症和左心室 (LV) 静缩功能障碍的患者提供了对HF进展的洞察力.
研究的目的:
- 测试结构重塑和细胞死亡有助于心力衰竭的进展的假设.
- 在患有大动脉狭窄的患者中,与左心室喷射率 (EF) 相关联结构变化.
主要方法:
- 与对照组相比,分析了患有隔离性膜大动脉狭窄症和不同EF水平 (高,中等,低) 的患者的LV肌切除术.
- 量化肌细胞缩,核DNA和Sc-35含量,纤维化,以及各种细胞死亡途径 (自,瘤,亡).
主要成果:
- 肌细胞缩与增加的核DNA和剪接因子含量有关.
- 纤维化和肌细胞退化随着EF的下降显著增加,与ACE和TGF-β1上调相关.
- 细胞损失,主要是通过自和瘤病变,随着LV缩功能障碍的恶化而大幅增加.
结论:
- 结构重塑,包括纤维化和肌细胞退化,以及细胞损失,驱动心力衰竭的进展.
- 涉及DNA合成和转录的过度缩起到了补偿作用.
- 自和瘤病是细胞死亡的关键机制,有助于左心室缩功能障碍的进展.
相关概念视频
Pathophysiology of Heart Failure
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

